Company: HROW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000925
Chunk: 1313

Company: HARROW, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 8
Chunk 1313
---
 Annual Meeting of Stockholders.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS,
AND DIRECTOR INDEPENDENCE

The information required by this
item is incorporated by reference to the information set forth under the captions “Corporate Governance — Transactions with
Related Persons” and “Corporate Governance — Director Independence” in the Company’s Proxy Statement for
the 2025 Annual Meeting of Stockholders.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information required by this
item is incorporated by reference to the information set forth under the caption “Ratification of Selection of Independent Registered
Public Accounting Firm” in the Company’s Proxy Statement for the 2025 Annual Meeting of Stockholders.

 69 

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

    (a)
    List of the following documents filed as part of the report:

    (1)
    See the index to our consolidated financial statements on page F-1
    for a list of the financial statements being filed in this Annual Report.

    (2)
    All financial statement schedules are omitted because they are not
    applicable or the required information is shown in the consolidated financial statements or the notes thereto.

    (3)
    See Item 15(b) below for all exhibits being filed or incorporated by
    reference herein.

    (b)
    Exhibits:

EXHIBIT INDEX 

    Exhibit 
    No.
     
    Description 

    2.1
     
    Agreement and Plan of Merger, dated as of September 17, 2007, by and among Imprimis Pharmaceuticals, Inc., Transdel Pharmaceuticals Holdings, Inc. and Trans-Pharma Acquisition Corp. Incorporation (incorporated herein by reference to Exhibit 2.1 to the Current Report on Form 8-K of Imprimis Pharmaceuticals, Inc. filed with the Securities and Exchange Commission on September 21, 2007).
  
    3.1
     
    Amended
    and Restated Certificate of Incorporation, as amended (incorporated herein by reference to Exhibit 3.1 to the Current Report on Form
    8-K of Harrow, Inc. filed with the Securities and Exchange Commission on September 29, 2023).
  
    3.2
     
    Amended and Restated Bylaws of Harrow, Inc. (incorporated herein by reference to Exhibit